Quick Stats

Bid Price - Offer Price -
Mid Price GBX 215.70 Day Change GBX +0.40 (0.19%)
Price Date 24 Nov 2017 Crown Rating 1
Shares Class Inc. Yield 0.10 %
Total Expense Ratio 0.00 Fund Size 44,860,300.00
Launch Date 02/01/2003 Standard Initial Charge (%) 0.00
Currency GBX ISA Eligible Yes
Annual Management Charge (%) 1.00 Sector IMA UK Equity Income
Min Investment (£) 3,000.00 Total Expense Ratio (%) 0.00
ISIN GB0033506725 Min TopUp (£) 1,000.00

Fund Objective

The Fund seeks to achieve capital growth, principally through investment in securities of US issuers.

Fund Managers

Sam Peters
Sam co-manages the Value Equity Strategy and the All Cap Value Strategy. He has 24 years of investment industry experience. Sam joined ClearBridge, LLC (f/k/a Legg Mason Capital Management, LLC) in 2005. Previously, Sam served as a Portfolio Manager and Health Care Sector Team Leader for Fidelity Management & Research. Sam joined Fidelity in 1999 as a bank analyst. He founded Samuel M. Peters Investment Advisors, an independent advisory firm. Sam was a financial consultant for Eppler, Guerin & Turner. Sam serves on the Board of Trustees for the Gilman School in Baltimore, Maryland, is a board member of the Merchant Livestock Company and is a board member emeritus of the College of William & Mary's Endowment Committee. Sam also serves on the Board of Trustees of the Santa Fe Institute, a leading, multi-disciplinary research laboratory dedicated to developing and advancing solutions to complex problems in physical, biological and social systems. Sam earned a BA in economics from the College of William & Mary and an MBA from the University of Chicago. He received the CFA designation in 1997.
Jean Yu
Jean co-manages the Value Equity Strategy. She has 15 years of investment industry experience. Jean joined ClearBridge, LLC (f/k/a Legg Mason Capital Management, LLC) in 2002 as a Research Analyst responsible for research in the health care sector as well as transportation logistical companies, industrial gas, and Chinese internet stocks. Previously, she worked as a Senior Business Analyst, managing consulting projects for Fortune 50 clients in the pharmaceutical industry at ISO Health Care Group. She received an MD from Beijing Medical University, an MBA from Duke University in Health Sector Management and Finance and a PhD in Molecular Biology from Columbia University. Jean received the CFA designation in 2006.